Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang Ouyang

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Acta Pharmaceutica Sinica. B|July 23, 2025
A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injuryLiang Ouyang
Journal of Medicinal Chemistry|February 27, 2026
First Selective Covalent FGFR3 Inhibitors: Conquering Toxicity and ResistanceLiang Ouyang
Journal of Medicinal Chemistry|August 29, 2024
<i>Journal of Medicinal Chemistry</i> Collection: Drug Discovery in ChinaBin Yu, Liang Ouyang
Future Medicinal Chemistry|November 23, 2020
Proteolysis-targeting chimeras in breast cancer therapyJifa Zhang, Liang Ouyang
Current Topics in Medicinal Chemistry|September 6, 2019
Epigenetic Regulation and Drug Discovery for Cancer TherapyBin Yu, Liang Ouyang
Journal of Medicinal Chemistry|September 24, 2024
Boosting Med Chem Education: Integrating Biology for Drug Discovery TalentsQiu Sun, Liang Ouyang
Drug Discovery Today|June 6, 2022
Drug repurposing: An effective strategy to accelerate contemporary drug discoveryPeng Zhan, Bin Yu, Liang Ouyang
Signal Transduction and Targeted Therapy|August 29, 2020
Promising inhibitors targeting M<sup>pro</sup>: an ideal strategy for anti-SARS-CoV-2 drug discoveryYi Chen, Guan Wang, Liang Ouyang
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2021
Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failureCongcong Lin, Huile Gao, Liang Ouyang
Future Medicinal Chemistry|June 22, 2017
What structural modifications can be used for BRD4 inhibitors for their use in leukemia therapy?Dahong Yao, Jie Liu, Liang Ouyang
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Acta Pharmaceutica Sinica. B|July 23, 2025
A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injuryLiang Ouyang
Journal of Medicinal Chemistry|February 27, 2026
First Selective Covalent FGFR3 Inhibitors: Conquering Toxicity and ResistanceLiang Ouyang
Journal of Medicinal Chemistry|August 29, 2024
<i>Journal of Medicinal Chemistry</i> Collection: Drug Discovery in ChinaBin Yu, Liang Ouyang
Future Medicinal Chemistry|November 23, 2020
Proteolysis-targeting chimeras in breast cancer therapyJifa Zhang, Liang Ouyang
Current Topics in Medicinal Chemistry|September 6, 2019
Epigenetic Regulation and Drug Discovery for Cancer TherapyBin Yu, Liang Ouyang
Journal of Medicinal Chemistry|September 24, 2024
Boosting Med Chem Education: Integrating Biology for Drug Discovery TalentsQiu Sun, Liang Ouyang
Drug Discovery Today|June 6, 2022
Drug repurposing: An effective strategy to accelerate contemporary drug discoveryPeng Zhan, Bin Yu, Liang Ouyang
Signal Transduction and Targeted Therapy|August 29, 2020
Promising inhibitors targeting M<sup>pro</sup>: an ideal strategy for anti-SARS-CoV-2 drug discoveryYi Chen, Guan Wang, Liang Ouyang
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2021
Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failureCongcong Lin, Huile Gao, Liang Ouyang
Future Medicinal Chemistry|June 22, 2017
What structural modifications can be used for BRD4 inhibitors for their use in leukemia therapy?Dahong Yao, Jie Liu, Liang Ouyang
Pageof 19